Stock INDEX INDEX PHARMACEUTICALS HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Company InDex Pharmaceuticals Holding AB

Equities

INDEX

SE0008966295

Pharmaceuticals

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:49 2024-04-26 am EDT 		5-day change 1st Jan Change
0.368 SEK +5.14% Intraday chart for InDex Pharmaceuticals Holding AB +11.85% +43.75%
Apr. 26 InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 05 Index Pharmaceuticals Holding AB Announces Board Resignations CI

Business Summary

InDex Pharmaceuticals Holding AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is focused in pharmaceuticals development. The Company's drug candidate is cobitolimod that helps in ulcerative colitis treatment. In addition, the Company develops a platform of patent protected substances, DNA based ImmunoModulatory Sequences (DIMS), that helps in the treatment of various immunological diseases. The Company also offers diagnostic kit DiBiCol, which is a PCR-based method that monitors seven biomarkers specific for ulcerative colitis or Crohn’s disease from a single colonic biopsy. InDex Pharmaceuticals Holding AB operates as a parent for InDex Pharmaceuticals AB and InDex Diagnostics AB. Among the Company's shareholders are SEB Venture Capital, Industrifonden and NeoMed Management.

Number of employees: 7

Sales per Business

SEK in Million2022Weight2023Weight Delta
Pharmaceuticals for Immunological Diseases
100.0 %
0 nan % 98 100.0 % -

Sales per region

SEK in Million2022Weight2023Weight Delta
Japan
100.0 %
-- 98 100.0 % -

Managers

Managers TitleAgeSince
Jenny Sundqvist CEO
 Chief Executive Officer 53 22-12-31
Johan Gileus DFI
 Director of Finance/CFO 59 17-04-30
Charlotte Admyre CTO
 Chief Tech/Sci/R&D Officer 45 -
Eva Arlander PRN
 Corporate Officer/Principal 60 22-05-01

Members of the board

Members of the board TitleAgeSince
Uli Alf Hacksell BRD
 Director/Board Member 74 15-12-31
Stig Lennart Hansson BRD
 Director/Board Member 68 10-12-31
Wenche Nelly A. Rolfsen Sandsborg CHM
 Chairman 72 10-12-31
Karin Bernadotte BRD
 Director/Board Member 61 21-12-31
Marlene Forsell BRD
 Director/Board Member 48 20-03-31
Anna-Kaija Grönblad BRD
 Director/Board Member 56 21-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 532,687,650 332,794,895 ( 62.47 %) 0 62.47 %

Company contact information

InDex Pharmaceuticals Holding AB

Berzelius vaeg 13

171 65, Solna

+46 8 12 20 38 50

http://www.indexpharma.com
address InDex Pharmaceuticals Holding AB(INDEX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.368 SEK
Average target price
0.535 SEK
Spread / Average Target
+45.38%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
INDEX PHARMACEUTICALS HOLDING AB Stock InDex Pharmaceuticals Holding AB
+43.75% 17.88M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. INDEX Stock
  4. Company InDex Pharmaceuticals Holding AB